FMS
Income statement / Annual
Last year (2024), Fresenius Medical Care AG & Co. KGaA's total revenue was $19.34 B,
a decrease of 0.61% from the previous year.
In 2024, Fresenius Medical Care AG & Co. KGaA's net income was $537.91 M.
See Fresenius Medical Care AG & Co. KGaA,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$19.34 B |
$19.45 B |
$19.40 B |
$17.62 B |
$17.86 B |
$17.48 B |
$16.55 B |
$17.78 B |
$17.03 B |
$15.31 B |
| Cost of Revenue |
$14.58 B
|
$14.53 B
|
$14.50 B
|
$12.85 B
|
$12.32 B
|
$12.08 B
|
$11.39 B
|
$11.78 B
|
$11.53 B
|
$10.43 B
|
| Gross Profit |
$4.76 B
|
$4.93 B
|
$4.89 B
|
$4.77 B
|
$5.54 B
|
$5.40 B
|
$5.16 B
|
$6.00 B
|
$5.50 B
|
$4.88 B
|
| Gross Profit Ratio |
0.25
|
0.25
|
0.25
|
0.27
|
0.31
|
0.31
|
0.31
|
0.34
|
0.32
|
0.32
|
| Research and Development Expenses |
$183.49 M
|
$231.97 M
|
$228.62 M
|
$220.78 M
|
$193.77 M
|
$168.03 M
|
$134.00 M
|
$131.00 M
|
$154.04 M
|
$128.05 M
|
| General & Administrative Expenses |
$2.37 B
|
$2.39 B
|
$2.37 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$776.53 M
|
$807.96 M
|
$800.88 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.14 B
|
$3.20 B
|
$3.17 B
|
$2.77 B
|
$3.13 B
|
$3.03 B
|
$2.87 B
|
$3.58 B
|
$2.90 B
|
$2.65 B
|
| Other Expenses |
$37.95 M
|
$127.26 M
|
-$17.06 M
|
-$72.87 M
|
-$94.52 M
|
-$73.68 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$3.36 B
|
$3.56 B
|
$3.38 B
|
$2.92 B
|
$3.23 B
|
$3.13 B
|
$3.00 B
|
$3.71 B
|
$3.05 B
|
$2.78 B
|
| Cost And Expenses |
$17.94 B
|
$18.08 B
|
$17.89 B
|
$15.77 B
|
$15.55 B
|
$15.21 B
|
$14.39 B
|
$15.49 B
|
$14.58 B
|
$13.21 B
|
| Interest Income |
$71.58 M
|
$88.22 M
|
$67.66 M
|
$73.17 M
|
$41.96 M
|
$61.62 M
|
$147.00 M
|
$51.38 M
|
$63.40 M
|
$105.07 M
|
| Interest Expense |
$407.04 M
|
$424.64 M
|
$360.14 M
|
$353.60 M
|
$409.98 M
|
$491.06 M
|
$448.00 M
|
$416.20 M
|
$426.81 M
|
$457.90 M
|
| Depreciation & Amortization |
$1.74 B
|
$1.75 B
|
$1.84 B
|
$1.62 B
|
$1.79 B
|
$1.59 B
|
$724.85 M
|
$735.48 M
|
$701.54 M
|
$655.81 M
|
| EBITDA |
$3.21 B |
$3.21 B |
$3.42 B |
$3.55 B |
$4.13 B |
$3.92 B |
$2.91 B |
$3.00 B |
$3.04 B |
$2.80 B |
| EBITDA Ratio |
0.17
|
0.16
|
0.18
|
0.2
|
0.23
|
0.22
|
0.18
|
0.17
|
0.18
|
0.18
|
| Operating Income Ratio |
0.07
|
0.07
|
0.08
|
0.11
|
0.13
|
0.13
|
0.18
|
0.13
|
0.15
|
0.14
|
| Total Other Income/Expenses Net |
-$335.47 M
|
-$336.42 M
|
-$292.48 M
|
-$280.43 M
|
-$368.02 M
|
-$429.44 M
|
-$301.06 M
|
-$364.82 M
|
-$363.41 M
|
-$352.83 M
|
| Income Before Tax |
$1.06 B
|
$1.03 B
|
$1.22 B
|
$1.57 B
|
$1.94 B
|
$1.84 B
|
$2.74 B
|
$2.01 B
|
$2.12 B
|
$1.77 B
|
| Income Before Tax Ratio |
0.05
|
0.05
|
0.06
|
0.09
|
0.11
|
0.11
|
0.17
|
0.11
|
0.12
|
0.12
|
| Income Tax Expense |
$316.06 M
|
$300.56 M
|
$324.95 M
|
$352.83 M
|
$500.56 M
|
$401.61 M
|
$511.00 M
|
$454.00 M
|
$649.42 M
|
$569.83 M
|
| Net Income |
$537.91 M
|
$499.00 M
|
$673.41 M
|
$969.31 M
|
$1.16 B
|
$1.20 B
|
$1.98 B
|
$1.28 B
|
$1.18 B
|
$941.19 M
|
| Net Income Ratio |
0.03
|
0.03
|
0.03
|
0.06
|
0.07
|
0.07
|
0.12
|
0.07
|
0.07
|
0.06
|
| EPS |
0.92 |
0.85 |
0.57 |
0.83 |
1.31 |
1.35 |
3.24 |
2.09 |
1.87 |
1.57 |
| EPS Diluted |
0.92 |
0.85 |
0.57 |
0.83 |
1.31 |
1.35 |
3.23 |
2.08 |
1.87 |
1.57 |
| Weighted Average Shares Out |
$587.88 M
|
$587.06 M
|
$1.17 B
|
$1.17 B
|
$888.24 M
|
$888.24 M
|
$614.55 M
|
$615.28 M
|
$613.39 M
|
$610.19 M
|
| Weighted Average Shares Out Diluted |
$586.83 M
|
$586.83 M
|
$1.17 B
|
$1.17 B
|
$887.33 M
|
$887.33 M
|
$614.45 M
|
$614.57 M
|
$612.66 M
|
$610.53 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
